Functional impairment in association with biofluid biomarkers of Alzheimer's disease in dementia‐free older adults

Abstract

Background: Dementia research is increasingly focused on developing methods for the early identification of individuals with underlying Alzheimer's disease (AD) pathology. Functional impairment (FI) is a key criterion for diagnosing dementia.